{
    "clinical_study": {
        "@rank": "156505", 
        "arm_group": [
            {
                "arm_group_label": "Caffeine", 
                "arm_group_type": "Experimental", 
                "description": "Caffeine 500mg"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Lactose 500mg"
            }
        ], 
        "brief_summary": {
            "textblock": "Heart failure patients represent a group of individuals at higher risk for cardiac\n      arrhythmias. There is a perception that caffeine consumption may represent an increase in\n      this risk. Although the medical staff and health professionals suggest a reduction in the\n      intake of this substance to patients considered at risk, there is no scientific proof for\n      this recommendation.\n\n      Some animal studies suggest a possible association between arrhythmias and caffeine use with\n      higher doses, but this finding did not appear in human studies. In particular, little is\n      known about the association between caffeine consumption and arrhythmias in patients with\n      heart failure, especially at higher doses of consumption.\n\n      More specific and safe guidelines on  caffeine consumption are needed."
        }, 
        "brief_title": "Arrhythmic Effects of Hight Dose Caffeine", 
        "condition": "Arrhythmia", 
        "condition_browse": {
            "mesh_term": "Arrhythmias, Cardiac"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Heart failure in NYHA functional class I-III\n\n          -  LV Ejection fraction <45%\n\n          -  Age > 18 y.o.\n\n          -  Cardio-defibrillator implanted with normal functioning with at least 30 days.\n\n        Exclusion Criteria:\n\n          -  Impossibility of take caffeine\n\n          -  Inability to perform an exercise test\n\n          -  Initial use of amiodarone in the last 2 months\n\n          -  Unstable ventricular arrhythmias, shock or ATP in the last 60 days\n\n          -  Hospitalization in the last two months due to decompensated heart failure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "112", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02045992", 
            "org_study_id": "110298"
        }, 
        "intervention": {
            "arm_group_label": "Caffeine", 
            "description": "Five doses of 100mg of caffeine diluted in 100 ml of decaffeinated coffee. One dose every hour for five hours", 
            "intervention_name": "caffeine", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": "Caffeine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 23, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Porto Alegre", 
                    "country": "Brazil", 
                    "state": "Rio Grande do Sul"
                }, 
                "name": "Hospital de Cl\u00ednicas de Porto Alegre"
            }, 
            "investigator": {
                "last_name": "Priccila Zuchinali", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of High-dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure - a Randomized Clinical Trial", 
        "overall_contact": {
            "email": "priccizuchi@gmail.com", 
            "last_name": "Priccila Zuchinali", 
            "phone": "5551 33598843"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Arrhythmias", 
            "safety_issue": "No", 
            "time_frame": "6 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02045992"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital de Clinicas de Porto Alegre", 
            "investigator_full_name": "Luis Eduardo Paim Rohde", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Hospital de Clinicas de Porto Alegre", 
        "sponsors": {
            "collaborator": {
                "agency": "Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Luis Eduardo Paim Rohde", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}